SEC CIK 1517890

Hall Patricia Hemingway

Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
CAHview stock →28,6452026-04-15
MANview stock →18,5402025-01-01
HALview stock →6,2992022-02-28

Position History — MAN

Reported shares owned immediately after each Form 4 transaction, over time.

07,22014,43921,6592014-052015-012017-012017-122019-012020-012023-012024-012025-01

Recent Filings — MAN

DateActivitySharesPriceOwned After
2025-01-01Grant / award (derivative)85$69.672,013
2025-01-01Grant / award (derivative)127$69.672,992
2025-01-01Option exercise (derivative)2,013—0
2025-01-01Option exercise2,013—18,540
2025-01-01Grant / award3,119$57.7221,659
2024-01-01Grant / award (derivative)69$78.681,928
2024-01-01Grant / award (derivative)103$78.682,865
2024-01-01Option exercise (derivative)2,132—0
2024-01-01Grant / award (derivative)77$78.682,132
2024-01-01Grant / award2,265$79.4716,527
2024-01-01Option exercise2,132—14,262
2023-01-01Grant / award (derivative)68$79.562,055
2023-01-01Grant / award (derivative)61$79.561,859
2023-01-01Grant / award (derivative)91$79.562,762
2023-01-01Grant / award2,103$83.2112,130
2022-01-01Grant / award (derivative)1,798$97.331,798
2022-01-01Grant / award (derivative)62$105.862,671
2022-01-01Grant / award (derivative)46$105.861,987
2021-01-01Grant / award (derivative)1,941$90.181,941
2021-01-01Grant / award (derivative)42$71.311,371
2021-01-01Option exercise (derivative)1,371—0
2021-01-01Grant / award (derivative)80$71.312,609
2021-01-01Option exercise1,371—10,027
2020-01-01Grant / award (derivative)60$90.162,529
2020-01-01Grant / award (derivative)31$90.161,329
2020-01-01Option exercise (derivative)1,738—0
2020-01-01Grant / award (derivative)41$90.161,738
2020-01-01Option exercise1,738—10,422
2020-01-01Grant / award1,802$97.108,684
2019-01-01Grant / award (derivative)29$87.981,298
2019-01-01Grant / award (derivative)38$87.981,697
2019-01-01Option exercise (derivative)1,766—0
2019-01-01Grant / award (derivative)2,469$64.802,469
2019-01-01Grant / award (derivative)40$87.981,766
2019-01-01Option exercise1,766—6,882
2018-01-01Grant / award (derivative)28$114.541,726
2018-01-01Grant / award (derivative)33$114.542,095
2018-01-01Option exercise (derivative)2,095—0
2018-01-01Grant / award (derivative)1,269$126.111,269
2018-01-01Grant / award (derivative)27$114.541,659
2018-01-01Option exercise2,095—5,116
2017-12-04Gift1,000$0.003,021
2017-12-04Open-market sale3,000$127.544,021
2017-01-01Grant / award (derivative)1,632$88.871,632
2017-01-01Grant / award (derivative)30$76.721,352
2017-01-01Option exercise (derivative)1,352—0
2017-01-01Grant / award (derivative)37$76.721,698
2017-01-01Grant / award (derivative)45$76.722,062
2017-01-01Option exercise1,352—7,021
2016-01-01Grant / award (derivative)24$85.431,322
2016-01-01Grant / award (derivative)1,661$84.291,661
2016-01-01Grant / award (derivative)37$85.432,017
2016-01-01Grant / award (derivative)48$85.432,589
2016-01-01Option exercise (derivative)2,589—0
2016-01-01Option exercise2,589—5,669
2015-01-01Grant / award (derivative)17$75.491,298
2015-01-01Grant / award (derivative)33$75.492,541
2015-01-01Option exercise (derivative)3,080—0
2015-01-01Grant / award (derivative)1,980$68.171,980
2015-01-01Grant / award (derivative)39$75.493,080
2015-01-01Option exercise3,080—3,080
2014-05-13Open-market sale1,096$83.500
2014-05-03Option exercise (derivative)1,096—0
2014-05-03Option exercise1,096—1,096
2014-01-01Grant / award (derivative)1,281$85.861,281
2014-01-01Grant / award (derivative)15$67.531,096
2014-01-01Grant / award (derivative)41$67.533,041
2014-01-01Grant / award (derivative)34$67.532,508
2013-01-01Grant / award (derivative)23$40.341,081
2013-01-01Grant / award (derivative)2,474$42.442,474
2013-01-01Grant / award (derivative)63$40.343,000
2012-01-01Grant / award (derivative)18$46.481,058
2012-01-01Grant / award (derivative)2,937$35.752,937
2011-05-03Grant / award (derivative)1,040$66.641,040

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.